$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
重度再生障碍性贫血患者治疗用药-艾曲波帕
2025-10-19 11:44:20
Check Details
血小板减少的诊断标准是什么?
2025-10-19 11:44:20
Check Details
哪些药物会诱发血小板减少?
2025-10-19 11:44:20
Check Details
诊断血小板减少的方式有哪些?
2025-10-19 11:44:20
Check Details
四个方面见证艾曲波帕的治疗效果
2025-10-19 11:44:20
Check Details
儿童血小板减少性紫癜如何选择药物?
2025-10-19 11:44:20
Check Details
四方面带您见证艾曲波帕的疗效
2025-10-19 11:44:20
Check Details
免疫性出血疾病服用艾曲波帕治疗效果更佳明显
2025-10-19 11:44:20
Check Details
艾曲波帕治疗慢性原发性血小板减少性紫癜
2025-10-19 11:44:20
Check Details
艾曲波帕的推荐剂量
2025-10-19 11:44:20
Check Details
艾曲波帕用于治疗慢性免疫性血小板减少性紫癜儿科患者
2025-10-19 11:44:20
Check Details
艾曲波帕的适用症
2025-10-19 11:44:20
Check Details
1
2
...
836
837
838
839
840
841
842
...
937
938
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
2
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
3
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
4
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
5
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
6
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
7
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
8
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
9
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
10
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
11
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
12
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor